EZZ Life Science Holdings Ltd. ( (AU:EZZ) ) just unveiled an announcement.
EZZ Life Science Holdings Limited reported a significant increase in both revenue and profit for the half-year ending December 31, 2024. Revenues rose by 39.6% to over $30 million, while profits surged by nearly 180% to approximately $3.2 million, attributed to increased marketing expenditures. The company’s EBITDA also saw a substantial rise, indicating strong operational performance. The announcement highlights EZZ Life Science’s robust financial health and strategic market positioning, which could positively impact stakeholders and enhance its competitive edge in the industry.
More about EZZ Life Science Holdings Ltd.
EZZ Life Science Holdings Limited operates in the life sciences industry, focusing on health and wellness products. The company is involved in the development and distribution of a range of consumer health products, with a market focus on improving quality of life.
YTD Price Performance: -34.85%
Average Trading Volume: 63,157
Technical Sentiment Consensus Rating: Buy
Current Market Cap: A$94.35M
Learn more about EZZ stock on TipRanks’ Stock Analysis page.